Volume 18, Issue 4 pp. 633-636
Short Paper
Full Access

Epitopes recognized by human t lymphocytes on malaria circumsporozoite protein

Francesco Sinigaglia

Corresponding Author

Francesco Sinigaglia

Central Research Units, F. Hoffmann-La Roche & Co. Ltd., Basel

F. Hoffmann-La Roche & Co. Ltd., Central Research Units, CH-4002 Basel, SwitzerlandSearch for more papers by this author
Maria Guttinger

Maria Guttinger

Central Research Units, F. Hoffmann-La Roche & Co. Ltd., Basel

Search for more papers by this author
Dieter Gillessen

Dieter Gillessen

Central Research Units, F. Hoffmann-La Roche & Co. Ltd., Basel

Search for more papers by this author
Daniel M. Doran

Daniel M. Doran

Central Research Units, F. Hoffmann-La Roche & Co. Ltd., Basel

Search for more papers by this author
BéLa Takacs

BéLa Takacs

Central Research Units, F. Hoffmann-La Roche & Co. Ltd., Basel

Search for more papers by this author
Hugues Matile

Hugues Matile

Central Research Units, F. Hoffmann-La Roche & Co. Ltd., Basel

Search for more papers by this author
Arnold Trzeciak

Arnold Trzeciak

Central Research Units, F. Hoffmann-La Roche & Co. Ltd., Basel

Search for more papers by this author
J. Richard Pink

J. Richard Pink

Central Research Units, F. Hoffmann-La Roche & Co. Ltd., Basel

Search for more papers by this author
First published: April 1988
Citations: 60

Abstract

The circumsporozoite protein of the malaria parasite Plasmodium falciparum contains regions of nonrepetitive sequences which are predicted to be T cell recognition sites. We synthesized peptides corresponding to three of these regions, and tested their ability to stimulate proliferation of peripheral blood lymphocytes from donors living in a malaria-endemic area, or from nonimmune donors. Cells from 15 out of 22 donors (including 4 of 6 nonimmune individuals) were stimulated by one or more of the peptides. T cell clones specific for one of the peptides were obtained and shown to recognize the native protein purified from sporozoites. These data help to identify T cell epitopes which could be incorporated into a malaria vaccine.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.